Curated News
By: NewsRamp Editorial Staff
May 07, 2024

Recce Pharmaceuticals Secures Global Patent Portfolio

Reddit Discuss on RedditDiscuss on Substack Discuss on Substack
Source Press Release

TLDR

  • Recce Pharmaceuticals secures new patents for powerful infection treatment compounds, gaining a competitive edge in major global pharmaceutical markets.
  • RECCE® 327 (R327) and RECCE® 529 (R529) are covered by a new patent for the treatment of bacterial infections, including methods of manufacture and administration.
  • Recce's new patent for infection treatment compounds will make the world a better place by providing effective solutions for common human infections, improving global healthcare.
  • China's pharmaceutical market, valued at approximately US$140 billion, is expected to continue growing, driven by increasing demand, healthcare reforms, and government support for pharmaceutical R&D.

Impact - Why it Matters

The formal granting of the new patent by the China National Intellectual Property Administration is a significant milestone for Recce Pharmaceuticals, ensuring patent protection in major global pharmaceutical markets. This news highlights the company's commitment to innovation in the treatment of common human infections, impacting the pharmaceutical industry and potential future healthcare solutions.

Summary

Recce Pharmaceuticals Ltd (ASX:RCE) CEO James Graham discusses the formal granting of a new Patent Family 2 by the China National Intellectual Property Administration. The patent covers RECCE® 327 (R327) and RECCE® 529 (R529), which are used in the treatment of common human infections. This ensures global patent protection for the company in major pharmaceutical markets, including China, Australia, the USA, Europe, and Japan. The CEO expressed gratitude towards the China National Intellectual Property Administration and emphasized the global coverage this patent secures.

Source Statement

This curated news summary relied on this press release disributed by News Direct. Read the source press release here, Recce Pharmaceuticals Secures Global Patent Portfolio

blockchain registration record for the source press release.